机译:口腔血浆Kallikrein抑制剂在遗传血管后血统的预防
Univ Hosp Frankfurt Div Hematol Oncol &
Hemostaseol Dept Children &
Adolescents Angioedema Ctr;
Odense Univ Hosp Dept Dermatol Odense Denmark;
Univ Sts Cyril &
Methodius Publ Hlth Inst Univ Clin Dermatol Sch Med Skopje Macedonia;
Charite Univ Med Berlin Dept Dermatol &
Allergy Berlin Germany;
Fraunhofer Inst Mol Biol &
Appl Ecol Translat Med &
Pharmacol Frankfurt Germany;
Univ Hosp Zurich Dept Clin Immunol Zurich Switzerland;
Sorbonne Univ Hop St Antoine AP HP Paris France;
Birmingham Heartlands Hosp Allergy &
Immunol West Midlands Birmingham W Midlands England;
Med Univ Vienna Dept Dermatol Vienna Austria;
Semmelweis Univ Hungarian Angioedema Reference Ctr Dept Internal Med 3 Budapest Hungary;
Hosp Univ Bellvitge LHospitalet de Llobregat Allergol Unit Dept Internal Med Barcelona Spain;
Barts Hlth NHS Trust Royal London Hosp London England;
Southampton Clin Res Facil Natl Inst Hlth Res Southampton Hants England;
Univ Salerno Div Allergy &
Clin Immunol Salerno Italy;
Med Univ Graz Dept Dermatol &
Venereol Graz Austria;
Univ Padua Dept Med Padua Italy;
Univ Milan Azienda Socio Sanitaria Territoriale Fatebenefrat Milan Italy;
Royal Adelaide Hosp Dept Clin Immunol &
Allergy Adelaide SA Australia;
Hosp Gen Univ Gregorio Maranon Biomed Res Network Rare Dis Ctr Invest Biomed Red Enfermedades;
Univ Montpellier Dept Dermatol Montpellier France;
Southmead Hosp North Bristol NHS Trust Bristol Avon England;
Hosp Univ Virgen Rocio Seville Spain;
Ulm Univ Med Ctr Dept Otorhinolaryngol &
Head &
Neck Surg Ulm Germany;
Hosp Univ Vall dHebron Vall dHebron Res Inst Barcelona Spain;
Western Sydney Univ Campbelltown Hosp Immunol &
Allergy Sydney NSW Australia;
BioCryst Pharmaceut Durham NC USA;
BioCryst Pharmaceut Durham NC USA;
BioCryst Pharmaceut Durham NC USA;
PharStat Durham NC USA;
BioCryst Pharmaceut Durham NC USA;
BioCryst Pharmaceut Durham NC USA;
Charite Univ Med Berlin Dept Dermatol &
Allergy Berlin Germany;
Univ Milan Azienda Socio Sanitaria Territoriale Fatebenefrat Milan Italy;
机译:口腔血浆Kallikrein抑制剂在遗传血管后血统的预防
机译:抑制血浆Kallikrein用于遗传性血统的预防
机译:口服血浆Kallikrein抑制剂BCX7353治疗遗传性血统
机译:蠕虫治疗遗传性血统血统:一种基于新型治疗选择的理论模型
机译:筛选天然产物对激肽释放酶激肽系统的影响:遗传性血管性水肿治疗的潜在影响。
机译:口服激肽释放酶抑制剂avoralstat在3期遗传性血管性水肿预防试验中的评估:OPuS-2研究
机译:口服血浆Kallikrein抑制剂BCX7353是安全有效的,作为遗传血统(HAE)患者的血管模型攻击的按需治疗:Zenith-1试验的结果
机译:阐明遗传性血管性水肿中突变型C1抑制蛋白增强毒性功能的机制。